{"transactions":[{"id":2878151,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":143027,"kind":"person","name":"Fjaellskog Marie-Louise","position":1,"cik":"0001843544","reported_name":"Fjaellskog Marie-Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option  (Right to Buy)","published_at":"2021-02-05T21:39:18.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":79166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the options granted hereby shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, February 3, 2021, thereafter one forty-eighth (1/48th) of the options granted shall vest and become exercisable each month following the Vesting Commencement Date, over four years such that the options shall be 100% vested on the fourth anniversary of the Vesting Commencement Date, subject to the grantee's Continuous Service (as defined in the 2021 Equity Incentive Plan) through each such vesting date."}],"balance_after":79166,"derivative":{"exercise_price":19,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":79166},"source":{"system":"sec-edgar","filing":"0001209191-21-008087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919121008087/doc4.xml","form_type":"4"}}]}